Selecta Biosciences Inc. | Key People and Executives
Omid C. Farokhzad
Chairman
Werner Cautreels
President, Chief Executive Officer & Director
Patrick J. Zenner
Independent Director
Timothy C. Barabe
Independent Director
Timothy A. Springer
Independent Director
Amir H. Nashat
Lead Independent Director
Peter Barton Hutt
Independent Director
Aymeric Sallin
Independent Director
Omid C. Farokhzad
Chairman
Werner Cautreels
President, Chief Executive Officer & Director
Lloyd Johnston
COO, Senior Vice President-Research & Development
John Harold Leaman
Chief Financial Officer & Treasurer
Takashi Kei Kishimoto
Chief Scientific Officer
Earl E. Sands
Chief Medical Officer
Stephen Smolinski
Chief Commercial Officer
David Abraham
Secretary & Chief Compliance Officer
Patrick J. Zenner
Independent Director
Timothy C. Barabe
Independent Director
Timothy A. Springer
Independent Director
Amir H. Nashat
Lead Independent Director
Peter Barton Hutt
Independent Director
Aymeric Sallin
Independent Director
| Address |
480 Arsenal Way
Watertown Massachusetts 02472
United States
|
|
Employees
|
- |
| Website |
http://www.selectabio.com |
| Updated |
07/08/2019 |
| Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies. |
